Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway

scholarly article

Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2008PNAS..10510119E
P356DOI10.1073/PNAS.0802753105
P932PMC publication ID2481335
P698PubMed publication ID18626012
P5875ResearchGate publication ID5226388

P50authorSalem ChouaibQ98108267
Fathia Mami-ChouaibQ100288215
P2093author name stringVladimir Lazar
Vincent Stroobant
Jean-François Baurain
Pierre G Coulie
Isabelle Vergnon
Faten El Hage
Hamid Echchakir
P2860cites workSignal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulinQ24532827
Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid dropletsQ24534284
Adoptive immunotherapy for cancer: building on successQ24546258
Cancer immunotherapy: moving beyond current vaccinesQ24548229
Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosisQ24679720
Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-EQ28181479
A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinomaQ28189622
Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesisQ28203510
Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopesQ28206209
Identification of signal peptide peptidase, a presenilin-type aspartic proteaseQ28206228
Signal peptide peptidase forms a homodimer that is labeled by an active site-directed gamma-secretase inhibitorQ28236978
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and CQ28263511
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide productsQ28264638
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processingQ28266416
Isolation and characterization of human calcitonin gene-related peptideQ28645701
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentationQ30434689
Degradation of cell proteins and the generation of MHC class I-presented peptidesQ33652524
The translocon: a dynamic gateway at the ER membraneQ33804360
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cellsQ33888972
Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.Q34035248
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptidesQ34372218
Proteolysis, proteasomes and antigen presentationQ35228583
The chemistry and enzymology of the type I signal peptidasesQ36280398
Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus proteinQ36365365
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigensQ36402611
A physiological role for calcitonin: protection of the maternal skeletonQ39568647
Calcitonin: physiology and pathophysiologyQ40295376
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinomaQ40351656
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survivalQ40809629
Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung.Q40890155
The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.Q40993314
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigenQ41870799
Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivoQ43001715
Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challengeQ45779304
The complete sequence of human preprocalcitoninQ48392537
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.Q53438021
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses.Q54528048
Signal sequences: more than just greasy peptidesQ56639128
3,4-Dichloroisocoumarin, a serine protease inhibitor, inactivates glycogen phosphorylase bQ58023511
Letter: Hypersecretion of calcitonin in neoplastic conditionsQ70010774
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumoursQ70019756
Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigenQ71655418
Expression of mage genes by non-small-cell lung carcinomasQ72272098
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancerQ72682038
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genesQ72992805
Non-traditionally derived CTL epitopes: exceptions that prove the rules?Q77723677
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccinationQ78536727
P433issue29
P407language of work or nameEnglishQ1860
P921main subjectcytotoxicityQ246181
P304page(s)10119-10124
P577publication date2008-07-14
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titlePreprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway
P478volume105

Reverse relations

cites work (P2860)
Q27023313A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens
Q24306596A protease-independent function for SPPL3 in NFAT activation
Q26864074Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome
Q28547947Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase Inhibitors
Q89965263Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children
Q37851046Generation of MHC class I ligands in the secretory and vesicular pathways
Q41533232Human Tumor Antigens and Cancer Immunotherapy
Q44315577Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.
Q59799214Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
Q99636466IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
Q64997870Identification of non-mutated neoantigens presented by TAP-deficient tumors.
Q47101668Insights into the mechanism of isoenzyme-specific signal peptide peptidase-mediated translocation of heme oxygenase
Q37851050Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
Q34512655NK Cell Maturation and Cytotoxicity Are Controlled by the Intramembrane Aspartyl Protease SPPL3.
Q46383217Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
Q60957167Preproinsulin Designer Antigens Excluded from Endoplasmic Reticulum Suppressed Diabetes Development in NOD Mice by DNA Vaccination
Q38269935Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex
Q92106808Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing
Q49432766Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
Q37844333Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development
Q38984568Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity
Q43290433Signal peptide peptidases are expressed in the shoot apex of rice, localized to the endoplasmic reticulum
Q37476307Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins.
Q38262570Signal peptides: new markers in cardiovascular disease?
Q38072774TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes
Q92628359TEIPP peptides: exploration of unTAPped cancer antigens
Q38984559Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
Q39593426The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through.
Q38818906The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis
Q39171951The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes
Q34315858mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies

Search more.